← Browse by Condition
Medical Condition

coronary artery disease cad

Total Trials
7
Recruiting Now
7
Trial Phases
Various

ClinicalMetric tracks all active clinical trials for coronary artery disease cad sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — coronary artery disease cad Clinical Trials

How many clinical trials are currently recruiting for coronary artery disease cad?
ClinicalMetric currently tracks 7 actively recruiting clinical trials for coronary artery disease cad, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 7. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for coronary artery disease cad?
coronary artery disease cad research spans multiple clinical trial phases. Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a coronary artery disease cad clinical trial?
Eligibility criteria for coronary artery disease cad trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Top Sponsors
Cairo University 1 trial
HeartFlow, Inc. 1 trial
Imperial College London 1 trial
University Medical Center Groningen 1 trial
Xueyan Zhao 1 trial

Recruiting Clinical Trials

NCT07248202
Recruiting
Ketamine-lidocaine Versus Ketamine-fentanyl for Induction of Anesthesia in Patients With Left Ventricular Systolic Dysfunction Undergoing Elective Coronary Artery Bypass
Enrollment
40 pts
Location
Egypt
Sponsor
Cairo University
View Trial →
NCT06831409
Recruiting
Using CTA Measures to Define Cardiac Risk In NFL Alumni
Enrollment
300 pts
Location
United States
Sponsor
HeartFlow, Inc.
View Trial →
NCT07386418
Recruiting
Study of Lesion-Specific Invasive Haemodynamic Angina Thresholds
Enrollment
60 pts
Location
United Kingdom
Sponsor
Imperial College London
View Trial →
NCT07269366
Recruiting
Surgical Versus Percutaneous Revascularization in Patients With Reduced Left Ventricular Function (STICH 3.0-NL)
Enrollment
358 pts
Location
Netherlands
Sponsor
University Medical Center Gron...
View Trial →
NCT07523880
Recruiting
Multi-Omics-Based Novel Thrombosis and Bleeding Markers and Risk Model for CHD
Enrollment
12,154 pts
Location
China
Sponsor
Xueyan Zhao
View Trial →
NCT07401550
Recruiting
Assessment and Prediction of Cardiovascular Health and Disease Risk Using Wearable Biometrics.
Enrollment
100 pts
Location
Ireland
Sponsor
University College Dublin
View Trial →
NCT07479056
Recruiting
Fexuprazan for Prevention of Upper Gastrointestinal Bleeding in High Bleeding Risk Patients Receiving Dual Antiplatelet Therapy
Enrollment
400 pts
Location
South Korea
Sponsor
SUK MIN SEO
View Trial →

Related Conditions

left ventricular lv systolic dysfunction (1) induction anesthesia (1) coronary bypass graft surgery (1) ketamine (1) fentanyl (1) lidocaine (1) heart disease (1) coronary atherosclerosis (1) angina stable (1) ischaemic heart disease ihd (1) coronary artery disease (1) multivessel coronary artery disease (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology